1. Home
  2. GNLX vs CHMI Comparison

GNLX vs CHMI Comparison

Compare GNLX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • CHMI
  • Stock Information
  • Founded
  • GNLX 2001
  • CHMI 2012
  • Country
  • GNLX United States
  • CHMI United States
  • Employees
  • GNLX N/A
  • CHMI N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • CHMI Real Estate Investment Trusts
  • Sector
  • GNLX Health Care
  • CHMI Real Estate
  • Exchange
  • GNLX Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • GNLX 85.0M
  • CHMI 92.0M
  • IPO Year
  • GNLX 2023
  • CHMI 2013
  • Fundamental
  • Price
  • GNLX $4.31
  • CHMI $3.39
  • Analyst Decision
  • GNLX Strong Buy
  • CHMI Buy
  • Analyst Count
  • GNLX 4
  • CHMI 3
  • Target Price
  • GNLX $18.25
  • CHMI $5.00
  • AVG Volume (30 Days)
  • GNLX 312.3K
  • CHMI 250.4K
  • Earning Date
  • GNLX 03-31-2025
  • CHMI 03-06-2025
  • Dividend Yield
  • GNLX N/A
  • CHMI 17.65%
  • EPS Growth
  • GNLX N/A
  • CHMI N/A
  • EPS
  • GNLX N/A
  • CHMI N/A
  • Revenue
  • GNLX $8,000.00
  • CHMI N/A
  • Revenue This Year
  • GNLX N/A
  • CHMI N/A
  • Revenue Next Year
  • GNLX N/A
  • CHMI $27.78
  • P/E Ratio
  • GNLX N/A
  • CHMI N/A
  • Revenue Growth
  • GNLX N/A
  • CHMI N/A
  • 52 Week Low
  • GNLX $1.60
  • CHMI $2.50
  • 52 Week High
  • GNLX $9.79
  • CHMI $3.99
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 75.11
  • CHMI 71.05
  • Support Level
  • GNLX $3.20
  • CHMI $3.07
  • Resistance Level
  • GNLX $4.23
  • CHMI $3.52
  • Average True Range (ATR)
  • GNLX 0.56
  • CHMI 0.09
  • MACD
  • GNLX 0.10
  • CHMI 0.03
  • Stochastic Oscillator
  • GNLX 95.73
  • CHMI 78.95

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: